← Back to patent-cliff list
CAS 28721-07-5
10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
Codes: Oxcarbazepine
Application context (from source-drug indications)
SeizureOxcarbazepine三叉神经痛OxcarbazepinePainOxcarbazepinePartial-onset seizureOxcarbazepineMultiple sclerosisOxcarbazepineEpilepsyOxcarbazepine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Oxcarbazepine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
10-methoxy-5H-dibenzo[b,f]azepine→10-methoxy-5H-dibenzo[b,f]azepine-5-carbonyl chloride→10-methoxy-5H-dibenzo[b,f]azepine-5-carboxamide→10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | Oxcarbazepine Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.